Vorinostat in Treating Patients With Kidney Cancer
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well vorinostat works in treating patients with advanced
kidney cancer. Drugs used in chemotherapy, such as vorinostat, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Vorinostat may also stop the growth of tumor cells by blocking blood flow to the tumor.